Many people who use these medications don’t want to stay on them long term. But research has repeatedly shown that quitting ...

Oprah Winfrey discusses GLP-1 weight-loss medications and obesity as a disease, challenging long-held misconceptions about ...

Clinical trials show retatrutide, Eli Lilly's new triple-agonist drug, delivered 24.2% weight loss in 48 weeks and the ...

Everything from AI-generated videos of celebrities to fake online pharmacies are being used to try to dupe consumers ...

Federal regulators are telling drugmakers to remove label warnings about potential suicidal thoughts and behaviors from their ...

When endocrinologist Dan Bessesen, MD, looked online and saw how easy it would be for him to purchase a weight loss drug from ...

A study previously carried out by Eli Lilly, the manufacturers of popular weight loss drug Mounjaro, found that of the 308 ...

Incorporating weight-loss interventions improved psoriasis severity and quality of life for patients with overweight or obesity, according to a systematic review and meta-analysis.Approximately 80% of ...

The U.S. health regulator on Tuesday asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk’s Wegovy and ...

This article was reviewed by Lynn Marie Morski, MD, JD Key Takeaways: Peptides are compounds made of amino acids linked by ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

There’s no question that medications like semaglutide (Wegovy) and tirzepatide (Zepbound) make headlines. They’re two of the handful of medications approved specifically for weight loss. While both ...